Literature DB >> 15476055

Transfusion risk for hepatitis B, hepatitis C and HIV in the state of Santa Catarina, Brazil, 1991-2001.

Emil Kupek1.   

Abstract

We examined the time trend of residual risk of transfusing blood contaminated with HIV, hepatitis B and hepatitis C, in the largest blood bank of the state of Santa Catarina, Brazil, 1991-2001. The HIV risk was reduced approximately 10 times during the decade of 1990, to 1:48777, but then increased significantly by the end of 2001. A similar time trend was observed for hepatitis B and hepatitis C, although the increase was not significant in this case. Even during the period of lowest risk, the estimates were considerably higher than in developed countries.

Entities:  

Mesh:

Year:  2004        PMID: 15476055     DOI: 10.1590/s1413-86702004000300007

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

1.  HIV Seroconversion in blood donors from the coordinating blood bank in the State of Pará.

Authors:  Andrea Silvestre Lobão Costa; Danielle Murici Brasiliense
Journal:  Rev Bras Hematol Hemoter       Date:  2011

2.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

3.  Comparison of epidemiological methods for estimation of hepatitis B incidence and residual risk for blood donors in southern Brazil.

Authors:  Emil Kupek; Andrea Petry
Journal:  J Transfus       Date:  2011-05-10

4.  A Study on Hepatitis B Viral Seromarkers and Associated Risk Factors among the Patients Suffering from Acute and Chronic Hepatitis B Infection.

Authors:  P Prabina; S Jayanthi; C Krishna Murthy; S Babu Kumar; As Shameem Banu; S R Sakunthala; J Perumal
Journal:  Int J Appl Basic Med Res       Date:  2019-10-11

5.  Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná.

Authors:  Heloise Skiavine Madeira; Claudinei Mesquita da Silva; Neila Cristina Scapini; Leyde Daiane de Peder; Jorge Juarez Vieira Teixeira
Journal:  Saudi Pharm J       Date:  2021-04-24       Impact factor: 4.330

6.  New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology.

Authors:  Svetlana Gorodin; Serhat Unal; Youchun Wang; Mikhail I Mikhaylov; Ludmila Bigbulatova; Tamar Jehuda-Cohen
Journal:  ScientificWorldJournal       Date:  2013-02-14

7.  Effectiveness of DNA-recombinant anti-hepatitis B vaccines in blood donors: a cohort study.

Authors:  Emil Kupek; Denise E R de Souza; Andrea Petry
Journal:  BMC Infect Dis       Date:  2007-11-06       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.